Brief: Botanix Pharmaceuticals Says FDA Approved Co's New Drug Application
20/06/2024 02:30
June 20 (Reuters) - Botanix Pharmaceuticals Ltd
BOT.AX :
* FDA APPROVED CO'S NEW DRUG APPLICATION FOR SOFDRA
(SOFPIRONIUM)
TOPICAL GEL
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million